The Boston Cognitive Assessment (BoCA) is a self-administered computerized test intended for longitudinal cognitive monitoring. BoCA uses random never repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.
ADCS-ADL assesses the competence of patients with Alzheimer’s Disease in basic and instrumental activities of daily living. ADCS-ADL is usually completed by a caregiver. All responses relate to the 4 weeks prior to the time of rating. The maximum total score is 78. Higher score indicates better level of competence.